Plain-English translation of NCT06067295 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that collects blood and urine samples from men with advanced prostate cancer as they begin a new treatment. The researchers are building a special collection of biological samples and health information that will help scientists understand how advanced prostate cancer develops and responds to treatment. This information could lead to better treatments in the future.
Advanced prostate cancer is a serious condition, and doctors need better ways to understand which treatments work best for different patients. By collecting samples and medical information from men starting new treatments, researchers hope to discover patterns that could help personalize care and develop more effective therapies.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will provide blood and urine samples at certain times. You will also complete surveys about your health and experiences, and the research team will review your medical records to track your treatment and health over time. There is no experimental medication involved — this is an observational study designed to learn from your experience as you receive your regular cancer treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI)
Enrollment target
~300 participants
Started
February 2023
Primary completion
December 2026
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cheryl Kefauver, RN
University of Southern California
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.